Is BRAF mutation screening useful for preoperative risk stratification in papillary thyroid cancer?

Paula Soares1, Manuel Sobrinho-Simões

  • 1Institute of Molecular Pathology & Immunology of the University of Porto (IPATIMUP), Rua Roberto Frias s/n, 4200-465 Porto, Portugal. psoares@ipatimup.pt

Abstract

No abstract available in PubMed .